Lycopene inhibits IGF-­-I signal transduction and growth in normal prostate epithelial cells by decreasing DHT-modulated IGF-I production in co­-cultured reactive stromal cells

Author(s): Liu X

Abstract

Prostate stromal and epithelial cell communication is important in prostate functioning and cancer development. Primary human stromal cells from normal prostate stromal cells (PRSC) maintain a smooth muscle phenotype, whereas those from prostate cancer (6S) display reactive and fibroblastic characteristics. Dihydrotestosterone (DHT) stimulates insulin-like growth factor-I (IGF-I) production by 6S but not PSRC cells. Effects of reactive versus normal stroma on normal human prostate epithelial (NPE or PREC) cells are poorly understood. We co-cultured NPE plus 6S or PRSC cells to compare influences of different stromal cells on normal epithelium. Because NPE and PREC cells lose androgen receptor (AR) expression in culture, DHT effects must be modulated by associated stromal cells. When treated with camptothecin (CM), NPE cells, alone and in stromal co-cultures, displayed a dose-dependent increase in DNA fragmentation. NPE/6S co-cultures exhibited reduced CM-induced cell death with exposure to DHT, whereas NPE/PRSC co-cultures exhibited CM-induced cell death regardless of DHT treatment. DHT blocked CM-induced, IGF-I-mediated, NPE death in co-cultured NPE/6S cells without, but not with, added anti-IGF-I and anti-IGF-R antibodies. Lycopene consumption is inversely related to human prostate cancer risk and inhibits IGF-I and androgen signaling in rat prostate cancer. In this study, lycopene, in dietary concentrations, reversed DHT effects of 6S cells on NPE cell death, decreased 6S cell IGF-I production by reducing AR and beta-catenin nuclear localization and inhibited IGF-I-stimulated NPE and PREC growth, perhaps by attenuating IGF-I's effects on serine phosphorylation of Akt and GSK3beta and tyrosine phosphorylation of GSK3. This study expands the understanding of the preventive mechanisms of lycopene in prostate cancer.

Similar Articles

Role of lycopene and tomato products in prostate health

Author(s): Stacewicz-Sapuntzakis M, Bowen PE

Plant extracts: sense or nonsense?CurrOpinUrol 18: 16-20

Author(s): Madersbacher S, Berger I, Ponholzer A, Marszalek M

Lycopene inhibits the growth of normal human prostate epithelial cells in vitro

Author(s): Obermüller-Jevic UC,Olano-Martin E, Corbacho AM, Eiserich JP, van der Vliet A, et al.

Lycopene reduced gene expression of steroid targets and inflammatory markers in normal rat prostate

Author(s): Herzog A, Siler U, Spitzer V, Seifert N, Denelavas A, et al.

Lycopene inhibits disease progression in patients with benign prostate hyperplasia

Author(s): Schwarz S,Obermüller-Jevic UC, Hellmis E, Koch W, Jacobi G, et al.

Diet adherence dynamics and physiological responses to a tomato product whole-food intervention in African-American men

Author(s): Park E,Stacewicz-Sapuntzakis M, Sharifi R, Wu Z, Freeman VL, et al.

Lycopene and prostate cancer

Author(s): Barber NJ, Barber J

Tomatoes, lycopene, and prostate cancer: progress and promise

Author(s): Hadley CW, Miller EC, Schwartz SJ, Clinton SK

A food-based formulation provides lycopene with the same bioavailability to humans as that from tomato paste

Author(s): Richelle M,Bortlik K, Liardet S, Hager C, Lambelet P, et al.

A physiological pharmacokinetic model describing the disposition of lycopene in healthy men

Author(s): Diwadkar-Navsariwala V, Novotny JA, Gustin DM, Sosman JA, Rodvold KA, et al.

Combinations of tomato and broccoli enhance antitumor activity in dunning r3327-h prostate adenocarcinomas

Author(s): Canene-Adams K,Lindshield BL, Wang S, Jeffery EH, Clinton SK, et al.

Combined lycopene and vitamin E treatment suppresses the growth of PC-346C human prostate cancer cells in nude mice

Author(s): Limpens J,Schröder FH, de Ridder CM, Bolder CA, Wildhagen MF, et al.

Chemoprevention of prostate cancer with lycopene in the TRAMP model

Author(s): Konijeti R, Henning S, Moro A, Sheikh A, Elashoff D, et al.

Antioxidants block prostate cancer in lady transgenic mice

Author(s): Venkateswaran V,Fleshner NE, Sugar LM, Klotz LH

Nutritional supplements, COX-2 and IGF-1 expression in men on active surveillance for prostate cancer

Author(s): Chan JM, Weinberg V, Magbanua MJ, Sosa E, Simko J, et al.

Lycopene effects on rat normal prostate and prostate tumor tissue

Author(s): Siler U, Herzog A, Spitzer V, Seifert N, Denelavas A, et al.

Effects of lycopene on protein expression in human primary prostatic epithelial cells

Author(s): Qiu X, Yuan Y, Vaishnav A, Tessel MA, Nonn L, et al.

Effect of lycopene on cell viability and cell cycle progression in human cancer cell lines

Author(s): Teodoro AJ, Oliveira FL, Martins NB, Maia Gde A, Martucci RB, et al.

A prospective study of lycopene and tomato product intake and risk of prostate cancer

Author(s): Kirsh VA,Mayne ST, Peters U, Chatterjee N, Leitzmann MF, et al.

Lycopene for the prevention of prostate cancer

Author(s): Ilic D, Forbes KM, Hassed C

A randomized trial of lycopene supplementation in Tobago men with high prostate cancer risk

Author(s): Bunker CH, McDonald AC, Evans RW, de la Rosa N, Boumosleh JM, et al.

Tomato sauce supplementation and prostate cancer: lycopene accumulation and modulation of biomarkers of carcinogenesis

Author(s): Bowen P, Chen L, Stacewicz-Sapuntzakis M, Duncan C, Sharifi R, et al.

Serenoarepens, lycopene and selenium versus tamsulosin for the treatment of LUTS/BPH

Author(s): Morgia G, Russo GI, Voce S, Palmieri F, Gentile M, et al.